How has been the historical performance of Abbott India?

Answer:The historical performance of Abbott India shows a consistent growth trajectory in key financial metrics over the years.

Breakdown:
Abbott India's net sales have steadily increased from INR 3,678.60 crore in March 2019 to INR 6,409.15 crore in March 2025, reflecting a robust annual growth. The total operating income followed a similar trend, rising from INR 3,678.60 crore in March 2019 to INR 6,409.15 crore in March 2025. The operating profit (PBDIT) also demonstrated significant growth, climbing from INR 718.02 crore in March 2019 to INR 1,970.18 crore in March 2025, with an operating profit margin that improved from 16.44% to 26.44% over the same period. Profit before tax increased from INR 698.85 crore in March 2019 to INR 1,886.95 crore in March 2025, and profit after tax rose from INR 450.33 crore to INR 1,414.44 crore, showcasing a healthy PAT margin growth from 12.24% to 22.07%. The company's total assets grew from INR 3,532.41 crore in March 2019 to INR 5,902.35 crore in March 2025, while total liabilities also increased from INR 3,532.41 crore to INR 5,902.35 crore, indicating a proportional rise in financial obligations. Cash flow from operating activities improved from INR 626 crore in March 2020 to INR 1,011 crore in March 2025, contributing to a closing cash and cash equivalent of INR 560 crore in March 2025, up from INR 145 crore in March 2020. Overall, Abbott India has shown strong financial performance with consistent growth across various metrics.